Coronary Artery Bypass Graft Market Size, Share & Trends Analysis Report By Procedure (Single CABG Surgery, Double CABG Surgery), By Method (On-pump, Off-pump), By End-use (Cardiology Centers, Hospitals), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global coronary artery bypass graft market size was valued at USD 12.03 billion and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030. This market growth can be attributed to the increasing prevalence of coronary heart disease (CHD) globally. As per the estimates of the WHO, cardiovascular disease is a leading cause of death globally, accounting for 17.9 million lives per year. Moreover, increasing incidences of other chronic disorders, such as diabetes and hypertension, also influence the growth of the Coronary Artery Bypass Grafting (CABG) market. As high blood sugar damages the heart’s blood vessels, this condition leads to a high risk of cardiovascular diseases.

The pandemic had a significant impact on the market. It led to a major disruption in the routine procedures of patients. In addition, many essential surgeries were halted, and the beds were allotted to COVID patients. However, eventually, it also positively impacted the market as several clinical studies showed that patients suffering from COVID-19 infection also have a high risk of developing a myocardial injury. Thus, the factor mentioned above led to a significant change in bypass surgery-related procedures.

The market is also growing due to increased myocardial infarction, an increasing geriatric population, and a favorable reimbursement scenario. According to the national library of Medicine estimate, myocardial infarction accounts for 3 million lives globally. In addition, as per the estimates of the United Nations, the geriatric population is expected to double by 1.5 billion in 2050. The geriatric population is more prone to cardiovascular diseases as fat deposits build up over the wall of arteries over a period of time. Moreover, a favorable reimbursement scenario is positively influencing the growth of this market.

Method Insights

The off-pump segment dominated the market in 2022 and accounted for a share of 53.8% of the total revenue. This growth can be attributed to benefits associated with the method, such as shorter hospital stays, smaller incisions, and faster recovery. In addition, it also reduces the risk of various postsurgical conditions, such as infection, arrhythmia, infection, and inflammation. Moreover, it offers better options to patients with cirrhosis, chronic lung conditions, and kidney problems.

Thus, the factors mentioned above are contributing to the growth of the market. The on-pump segment is estimated to register the fastest growth rate over the forecast period with a CAGR of 9.5% this growth can be attributed to the benefit associated with this procedure over off-pump bypass surgery. Studies show that off-pump bypass surgeries could lead to increased mortality rate and higher prevalence of recurring angina, this factor is overall positively influencing the market growth for the segment.

Procedure Insights

Based on the procedure, the market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery, and quadruple CABG surgery. The single CABG surgery segment accounted for the highest revenue share of 32.7% in 2022 and is also expected to grow at the fastest CAGR of 9.8% over the forecast period. One of the most frequent major procedures is CABG and the treatment highly depends on one or more cardiac arteries that are blocked. The three coronary arteries of the heart are not all equal.

The Left Anterior Descending (LAD) artery is referred to as the most significant artery. A constriction or blockage in the LAD artery is more severe than a blockage in the other arteries. The left anterior descending artery can get blocked, which can result in a catastrophic heart attack. In most cases, bypass surgery is the best option for a blocked LAD artery. The high adoption of bypass surgery for treating LAD contributes to the single CABG segment market growth.

End-use Insights

On the basis of end-uses, the hospital segment dominated the market in 2022 and accounted for the highest share of 52.8% of the total revenue. This can be attributed to technological advancements that aid in treating complex medical conditions at hospitals. Hospitals have a wide range of access to diagnostic equipment that aids in treating chronic conditions. Thus, this factor is contributing to the growth of the segment. In addition, the presence of major hospitals, such as Cleveland Clinic, contributes to the higher share of the segment.

Cleveland Clinic consistently ranks among the best hospital systems in the world and the United States, and it is especially well-regarded in terms of technical management systems. The cardiology centers segment is expected to witness the fastest growth rate of 9.7% over the forecast period. This growth can be attributed to an increase in privately owned specialty centers for diagnosing and treating diseases specific to the cardiovascular system.

Regional Insights

North America dominated the global market and accounted for a share of 47.5% of the total revenue in 2022. This growth can be attributed to the high prevalence of cardiovascular diseases across the region and technological advancements that offer patients off-pump and on-pump bypass procedures. In addition, many private institutions and Centers for Medicare & Medicaid Services (CMS) offer reimbursement coverage for medical devices and surgeries. All these factors are driving the market growth in the region.

Asia Pacific is expected to witness the fastest CAGR of 9.7% over the forecast period. This growth can be attributed to various factors, such as the increasing geriatric population in economies like India and China. As per the estimates of the WHO, by 2040, an estimated 402 million of the total population in China will be aged more than 60 years. These countries also have a high rate of CHD mortality. Thus, the above-mentioned factors are contributing to the growth of the Asia Pacific regional market.

Key Companies & Market Share Insights

The market is highly competitive due to the presence of a large number of manufacturers. The market players are focusing on various strategic initiatives, such as new product launches, geographical expansions, mergers & acquisitions, and collaborations & partnerships. For instance, in August 2022, Medtronic completed the acquisition of Affera, Inc. This acquisition is expected to increase the cardiovascular product portfolio of the company. Some of the major participants in the global coronary artery bypass graft market include:

• Medtronic

• Terumo Corporation

• Guidant Group

• MAQUET Holding B.V. & Co.KG

• Vitalitec International, Inc.

• Novadaq Technologies Inc.

• KARL STORZ GmbH & Co. KG

• Edwards Lifesciences

• Genesee Biomedical Inc.

• Sorin Group

Coronary Artery Bypass Graft Market Report Scope

Global Coronary Artery Bypass Graft Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global coronary artery bypass graft market report based on method, procedure, end-use, and region:

• Method Outlook (Revenue, USD Billion, 2018 - 2030)

  • Off-pump

  • On-pump

  • Minimally Invasive Direct

• Procedure Outlook (Revenue, USD Billion, 2018 - 2030)

  • Single CABG Surgery

  • Double CABG Surgery

  • Triple CABG Surgery

  • Quadruple CABG Surgery

• End-Use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Hospitals

  • Cardiology Centers

  • Others

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait